Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu
  • quotes

  • charts

  • technicals

  • company

Cannabis Science Inc (CBIS) OTHER OTC

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0408 +197.06%
on 12/21/16
0.1395 -13.12%
on 01/20/17
+0.0811 (+202.24%)
since 12/20/16
3-Month
0.0271 +347.23%
on 11/23/16
0.1395 -13.12%
on 01/20/17
+0.0542 (+80.90%)
since 10/20/16
52-Week
0.0101 +1,100.00%
on 03/03/16
0.1395 -13.12%
on 01/20/17
+0.1095 (+935.90%)
since 01/20/16

Most Recent Stories

More News
Cannabis Science Inc. (CBIS) and Dana Farber/Harvard Cancer Center (DF/HCC) Announce Joint Research and Drug Development Agreement; Collaborative Research Agreement

This Agreement allows both Cannabis Science and Dana Farber/Harvard Cancer Center to leverage one another's operating strengths to explore pre-clinical research and develop new cannabinoid-based cancer...

Small Companies in the Cannabis Sector With News

http://www.Financialbuzz.com - Over the recent few years, and in 2016 in particular, the legal cannabis industry has accomplished some significant milestones. Most importantly is the change of public opinion...

The Next Biggest Industry Could Potentially Be Cannabis

The state of California is anticipated to triple the size of the legal cannabis market when the state begins issuing licenses in 2018, which makes up 12 percent of the United States, according to market...

Harvard Director of Global Health Catalyst at the World-Renowned Dana Farber/Harvard Cancer Center States: Cannabis Science Presentation and Discussions a Great Success for Mutually Beneficial Partnership Opportunities with Harvard Medical School

IRVINE, CA--(Marketwired - Nov 21, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, proudly announced that following its presentation...

Cannabis Science Announces Initiation of Studies into Intravenous Therapy (IV) Transfer of CBD/THC Rich Extracts for Pulmonary Patients

IRVINE, CA--(Marketwired - Nov 16, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce that plans to initiate...

Cannabis Science Announces Initiation of Studies into Intravenous Therapy (IV) Transfer of CBD/THC Rich Extracts for Pulmonary Patients

IRVINE, CA--(Marketwired - Nov 16, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce that plans to initiate...

Legal Cannabis Industry Anticipates Growth

http://www.Financialbuzz.com - The share of Americans who favor legalizing the use of legal cannabis continues to increase. According to Pewresearch, 57% of U.S. adults say the use of cannabis should be...

Cannabis Science Begins Buildout of 33,000 Sq. Ft. Greenhouse Space for its First Douglas County, Nevada Cannabinoid Drug Development Land Deal

IRVINE, CA--(Marketwired - Nov 15, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, has begun its first cannabinoid drug...

Cannabis Science Begins Buildout of 33,000 Sq. Ft. Greenhouse Space for its First Douglas County, Nevada Cannabinoid Drug Development Land Deal

IRVINE, CA--(Marketwired - Nov 15, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, has begun its first cannabinoid drug...

Cannabis Science Targets Rapid Expansion as it Opens New Negotiations for over 1,000 Acres Targeting Property/Drug Development in California and Nevada as Industry Opens Up

IRVINE, CA--(Marketwired - Nov 10, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is prepared to move in on new opportunities...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is in the Top 1%. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Support & Resistance

2nd Resistance Point 0.1531
1st Resistance Point 0.1371
Last Price 0.1212
1st Support Level 0.1076
2nd Support Level 0.0941

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.